XenoTherapeutics Foundation is dedicated to the continued research and development of xenotransplantation tissues and organs for therapeutic use. The Foundation focuses on product discovery and preclinical testing and works with our for-profit venture partner to de-risk and optimize therapeutic candidates while decreasing the time to market.

The Work

"In 1982, our senior colleague, Thomas Starzl, one of the great pioneers of allotransplantation, wrote: ‘History tells us that procedures which were inconceivable yesterday, and are barely achievable today, often become routine tomorrow.’

 

We believe that, with the novel genetically-engineered pigs becoming available to us, clinical pig organ and cell transplantation, inconceivable only a few years ago and barely achievable today, will become routine tomorrow. Indeed, allotransplantation will eventually become of historic interest only."

—  David Cooper, David Ayares - The role of genetically engineered pigs in  xenotransplantation research; Journal of Pathology, 2016: 288-299

QUOTES

 
Contact Us
Contact Information

Innovation Office & Mailing Address 
359 Newbury St
Boston MA 02115

 

 

Tel: 617-939-7892

​

Email: info@xenotherapeutics.org

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon

© 2019 by  XenoTherapeutics. All Rights Reserved.

xenotransplantation; xenograft; burns; biotechnology; wound; organs; skin graft; burn treatment; transplant; organ donation;